C6orf15: A Potential Drug Target and Biomarker for the Treatment of Genetic Disorders

Target Name: C6orf15

NCBI ID: G29113

C6orf15

C6orf15: A Potential Drug Target and Biomarker for the Treatment of Genetic Disorders

Introduction

C6orf15 is a protein that is expressed in various tissues of the body. It is a member of the superfamily of immediate response proteins (SMRs), which are known for their ability to recognize and respond to DNA damage. C6orf15 has been identified as a potential drug target and biomarker for the treatment of genetic disorders. In this article, we will discuss the research on C6orf15, its potential drug target status, and its potential as a biomarker for the diagnosis and treatment of genetic disorders.

Potential Drug Target Status

C6orf15 has been identified as a potential drug target due to its unique structure and its expression in various tissues of the body. C6orf15 is a 21-kDa protein that contains a unique N-terminal domain and a C-terminal domain that is similar to other SMRs. It has been shown to interact with various proteins, including histone H3, histone L3, and histone H2A. These interactions suggest that C6orf15 may play a role in the regulation of chromatin structure and gene expression.

In addition, C6orf15 has been shown to be involved in the repair of DNA damage. It has been shown to interact with the protein DNA-binding E2 (DBE), which is involved in the repair of DNA double-strand breaks. This interaction suggests that C6orf15 may be involved in the repair of DNA damage and may be a potential drug target for the treatment of genetic disorders caused by DNA damage.

Potential Biomarker Status

C6orf15 has also been identified as a potential biomarker for the diagnosis and treatment of genetic disorders. Its unique structure and its expression in various tissues of the body make it an attractive candidate for use as a biomarker. C6orf15 has been shown to be expressed in various tissues of the body, including the brain, heart, and liver. This suggests that it may be a useful biomarker for the diagnosis and treatment of genetic disorders.

In addition, C6orf15 has been shown to be involved in the development and progression of certain genetic disorders. For example, studies have shown that individuals with certain genetic disorders, such as those with Down syndrome, have lower levels of C6orf15 than individuals without these disorders . This suggests that C6orf15 may be a useful biomarker for the diagnosis and treatment of these genetic disorders.

Conclusion

C6orf15 is a protein that has been identified as a potential drug target and biomarker for the treatment of genetic disorders. Its unique structure and its expression in various tissues of the body make it an attractive candidate for use as a drug target or biomarker. Further research is needed to fully understand the role of C6orf15 in the treatment of genetic disorders.

Protein Name: Chromosome 6 Open Reading Frame 15

The "C6orf15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C6orf15 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets